Extended report
Relative serum amyloid A (SAA) values: the influence of SAA1
genotypes and corticosteroid treatment in Japanese patients with
rheumatoid arthritis
T Yamadaa, Y Okudab, K Takasugib, K Itohc, J Igaria
a Department of
Clinical Pathology, Juntendo University School of Medicine, Tokyo,
Japan, b Centre
for Rheumatic Diseases, Dohgo Spa Hospital, Matsuyama, Japan, c Department of Clinical
Laboratory Medicine, Jichi Medical School, Tochigi, Japan
Correspondence to: Dr T Yamada, Department of Clinical Pathology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421 Japan toshiyam{at}med.juntendo.ac.jp
Accepted for publication 7 June 2000
OBJECTIVES
(1) To
determine whether serum concentration of serum amyloid A (SAA) protein
is influenced by the SAA1 allele in Japanese patients with rheumatoid
arthritis (RA) as previously shown in a healthy control group; and (2)
to analyse what factors, based on such an allelic bias, influence the
relative SAA values of those patients.
METHODS
SAA and C
reactive protein (CRP) concentrations together with SAA1 genotypes were
determined in 316 Japanese patients with RA. The relative SAA values
were evaluated as an SAA/CRP ratio.
RESULTS
Comparison of
the three SAA1 homozygote groups showed that the SAA/CRP ratio was
highest in the 1.5/1.5 group (mean 9.0, p<0.01 v the other two homozygote groups) followed
by the 1.3/1.3 group (mean 7.2, NS v the
1.1/1.1 group) and the 1.1/1.1 group (mean 4.0). The SAA/CRP ratio was
significantly higher in patients receiving corticosteroids regardless
of the presence of allele 1.5. No clear differences in the ratio
between patients with or without amyloidosis were found.
CONCLUSION
The SAA1.5
allele and corticosteroid treatment had a positive influence on SAA
concentrations in serum. These findings are important when evaluating
SAA concentration in inflammatory diseases and when considering the
cause or treatment of amyloidosis.
© 2001 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
van der Hilst, J. C. H., Yamada, T., Op den Camp, H. J. M., van der Meer, J. W. M., Drenth, J. P. H., Simon, A.
(2008). Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis. Rheumatology (Oxford)
47: 1651-1654
[Abstract] [Full Text] -
Christenson, K., Bjorkman, L., Tangemo, C., Bylund, J.
(2008). Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1. J. Leukoc. Biol.
83: 139-148
[Abstract] [Full Text] -
Nakamura, T., Higashi, S., Tomoda, K., Tsukano, M., Baba, S., Shono, M.
(2006). Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology (Oxford)
45: 43-49
[Abstract] [Full Text] -
Yamada, T.
(2004). Genetic Effects on Serum Concentrations of Serum Amyloid A Protein. Clin. Chem.
50: 978-979
[Full Text] -
Thorn, C. F., Whitehead, A. S.
(2002). Differential Glucocorticoid Enhancement of the Cytokine-Driven Transcriptional Activation of the Human Acute Phase Serum Amyloid A Genes, SAA1 and SAA2. J. Immunol.
169: 399-406
[Abstract] [Full Text] -
Rau, R., Herborn, G., Menninger, H., Sangha, O.
(2002). Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients. Rheumatology (Oxford)
41: 196-204
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
